Ephrin-B stimulation of calvarial bone formation

2012 ◽  
Vol 241 (12) ◽  
pp. 1901-1910 ◽  
Author(s):  
M. Douglas Benson ◽  
Lynne A. Opperman ◽  
Jan Westerlund ◽  
Claudia R. Fernandez ◽  
Symone San Miguel ◽  
...  
2021 ◽  
Vol 9 (3) ◽  
pp. 24
Author(s):  
Brian Heubel ◽  
Anja Nohe

The osteogenic effects of Bone Morphogenetic Proteins (BMPs) were delineated in 1965 when Urist et al. showed that BMPs could induce ectopic bone formation. In subsequent decades, the effects of BMPs on bone formation and maintenance were established. BMPs induce proliferation in osteoprogenitor cells and increase mineralization activity in osteoblasts. The role of BMPs in bone homeostasis and repair led to the approval of BMP2 by the Federal Drug Administration (FDA) for anterior lumbar interbody fusion (ALIF) to increase the bone formation in the treated area. However, the use of BMP2 for treatment of degenerative bone diseases such as osteoporosis is still uncertain as patients treated with BMP2 results in the stimulation of not only osteoblast mineralization, but also osteoclast absorption, leading to early bone graft subsidence. The increase in absorption activity is the result of direct stimulation of osteoclasts by BMP2 working synergistically with the RANK signaling pathway. The dual effect of BMPs on bone resorption and mineralization highlights the essential role of BMP-signaling in bone homeostasis, making it a putative therapeutic target for diseases like osteoporosis. Before the BMP pathway can be utilized in the treatment of osteoporosis a better understanding of how BMP-signaling regulates osteoclasts must be established.


2007 ◽  
Vol 22 (7) ◽  
pp. 1020-1030 ◽  
Author(s):  
Hideyuki Hirasawa ◽  
Shinya Tanaka ◽  
Akinori Sakai ◽  
Masato Tsutsui ◽  
Hiroaki Shimokawa ◽  
...  

2002 ◽  
Vol 99 (7) ◽  
pp. 4580-4585 ◽  
Author(s):  
K. Yoshida ◽  
H. Oida ◽  
T. Kobayashi ◽  
T. Maruyama ◽  
M. Tanaka ◽  
...  

2021 ◽  
Vol 3 (3) ◽  
pp. 23-30
Author(s):  
V.P. Kuznetsov ◽  
A.A. Emanov ◽  
E.N. Gorbach ◽  
V.G. Gorgots

Author(s):  
Hyun Seon Jang ◽  
Kwang Ho Lee ◽  
Moon Jin Jeong ◽  
Joo Cheol Park ◽  
Heung Joong Kim ◽  
...  

2020 ◽  
Vol 1010 ◽  
pp. 549-554
Author(s):  
Khairul Anuar Shariff ◽  
Mohamad Hafizi Abu Bakar ◽  
Arief Cahyanto

The aim of this study is to investigate the behavior of osteoclast cells response on dicalcium phosphate dihydrate (DCPD) layer-coated β-TCP granules. β-TCP granules with 300-600 μm were exposed to acidic calcium phosphate solution for 30 mins in order to get 10 mol% DCPD layer-coated β-TCP granular. DCPD free-coated β-TCP granular had used as control specimen. Both specimens were implant in 9 mm of rat calvarial bone defect for 4 weeks. After 4 weeks, the block section of rat calvarial containing specimen were removed for Tatrate-Resistance Acid Phosphatase (TRAP) analysis. Results of TRAP staining reveal that the number of osteoclast cells attached on 10 mol% layer-coated β-TCP granular is higher than DCPD free-coated β-TCP granular. Since remodeling of new bone formation involved simultaneous osteoclast and osteoblast cells response, therefore, the results obtained in this study indicated that the presence of DCPD layer-coated on β-TCP granular helps to improve osteoclast cells response that contribute in stimulating new bone formation.


Sign in / Sign up

Export Citation Format

Share Document